StopDown
4baseCare logo
Funding · 11 June 20264baseCareRs 128 CrGenomics-driven cancer diagnostics4basecare.com ↗

4baseCare raises Rs 128 Cr in Series B round

By · Editor ·

Series BFounded 2019
  • 4baseCare provides AI-led genomic cancer diagnostics through its OncoTwin platform
  • The company closed a Series B round of Rs 128 Cr with growX Ventures leading the top-up
  • Funds support global expansion and lower pricing for underrepresented populations

What happened

  • 4baseCare has closed its Series B funding round totaling Rs 128 Cr.
  • The total amount includes an earlier tranche of Rs 90 Cr and a top-up of Rs 38 Cr.
  • growX Ventures led the top-up investment round with participation from existing backers.
  • Infosys participated as a strategic innovation investor in this latest funding stage.
  • Co-lead investors for the initial Series B tranche were Ashish Kacholia and Lashit Sanghvi.
  • Existing backer Yali Capital also participated in the current funding round.
  • The company reported annual revenue of approximately Rs 40 Cr at the time of closing.
  • 4baseCare aims to cross Rs 100 Cr in revenue within the next 12-18 months.

Why it matters

  • India sees around 15 lakh new cancer cases annually according to market context.
  • Approximately 70% of these cases are diagnosed at advanced stages in India.
  • The startup addresses the underrepresentation of non-Caucasian populations in genomic data globally.
  • Adoption is spreading from tier 1 cities to tier 2 and tier 3 locations.

The business

  • 4baseCare focuses on precision oncology and genomics-driven cancer diagnostics services.
  • Its core product is the OncoTwin platform which uses AI clinical decision support.
  • The platform analyzes multimodal datasets including genomic, pathology, radiology, and clinical data.
  • The company operates 4 active labs currently within India.
  • It performs approximately 1,500 genomic tests per month at present capacity.
  • Projected monthly test volume is expected to reach 8,000-10,000 tests soon.
  • The firm pursues a strategy of lower prices compared to competitors.
  • Some offerings cost nearly one-fourth of what competitor services charge.

The founders

Hitesh Goswami

Co-founder and CEO

Kshitij Rishi

Co-founder

Who put in money

In numbers

Rs 128 CrTotal Funding Raised · 2026
Rs 40 CrAnnual Revenue · 2026
1,500Monthly Tests · 2026
4Active Labs · 2026

What happens next

  • Plans to expand lab network to Middle East, Southeast Asia, Latin America, and Central Asia.
  • Targeting entry into 8-10 additional countries over the next 12-18 months.
  • Forming partnerships with Max Healthcare, AIIMS Jammu, and Shankara Hospital for in-hospital labs.
  • Aiming to decentralize testing access across India through hospital integrations.

Earlier rounds

  • 2024 · Series A · Rs 50 Cr · led by Yali Capital
  • Jan 2026 · Series B Tranche 1 · Rs 90 Cr · led by Ashish Kacholia, Lashit Sanghvi

Words to know

Precision Oncology
Tailoring cancer treatment based on individual genetic makeup and disease characteristics.
Genomics
The study of an organism's complete set of DNA including all genes.
Multimodal Datasets
Combining different types of data such as images, text, and genetic sequences for analysis.
Clinical Decision Support
Systems that help healthcare providers make better medical decisions using data and AI.

The numbers around it

4baseCare has 2 funding rounds in StopDown's archive, Rs 128 Cr raised in all.

#The numbers around it
WhenRoundAmountLed by
27 January 2026series-b₹90 croreAshish Kacholia

Healthcare & Life Sciences in June 2026: 11 rounds with a disclosed amount, $118 million in all; the biggest was Vetic ($40 Mn). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.

Everything on 4baseCare → · All startup news on 11 June 2026 →

Is this 4baseCare? Get your “Featured on StopDown” badge →